Advantage Trust Co grew its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 60.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 798 shares of the company’s stock after purchasing an additional 300 shares during the period. Advantage Trust Co’s holdings in Colgate-Palmolive were worth $73,000 at the end of the most recent quarter.
Other hedge funds have also modified their holdings of the company. Grimes & Company Inc. grew its holdings in Colgate-Palmolive by 1.0% during the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after acquiring an additional 118 shares during the period. RFG Advisory LLC grew its holdings in Colgate-Palmolive by 1.4% during the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock worth $839,000 after acquiring an additional 123 shares during the period. Redhawk Wealth Advisors Inc. grew its holdings in Colgate-Palmolive by 2.4% during the second quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock worth $497,000 after acquiring an additional 129 shares during the period. MONECO Advisors LLC grew its holdings in Colgate-Palmolive by 2.2% during the first quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock worth $567,000 after acquiring an additional 133 shares during the period. Finally, Ledyard National Bank grew its holdings in Colgate-Palmolive by 4.5% during the first quarter. Ledyard National Bank now owns 3,094 shares of the company’s stock worth $290,000 after acquiring an additional 134 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
CL has been the topic of several analyst reports. The Goldman Sachs Group dropped their target price on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a report on Thursday, October 2nd. UBS Group dropped their target price on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a research report on Thursday, September 25th. Finally, Bank of America lowered their price target on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $91.50.
Colgate-Palmolive Stock Performance
Shares of CL stock opened at $78.76 on Tuesday. The company has a market capitalization of $63.65 billion, a P/E ratio of 22.12, a P/E/G ratio of 4.64 and a beta of 0.34. The business’s 50 day moving average is $81.85 and its two-hundred day moving average is $87.19. Colgate-Palmolive Company has a 12-month low of $76.68 and a 12-month high of $100.49. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.91 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.43%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- Following Congress Stock Trades
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 High-Yield Banks for Investors to Buy on the Dip
- What is a buyback in stocks? A comprehensive guide for investors
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.